Literature DB >> 11714946

HIV seroconversion interval and demographic characteristics: no evidence of selection bias.

P Vanhems1, R Allard, M Dhénain, C Chidiac, D Peyramond, J L Touraine, C Trépo, J Ritter, J Fabry.   

Abstract

OBJECTIVES: To determine if the interval between the last negative and the first positive HIV test is associated with demographic characteristics of HIV seroconverters.
METHODS: A prospective cohort of patients with HIV seroconversion enrolled in the Lyons HIV hospital database was analysed. Comparisons of demographic characteristics were performed after stratification on the duration of the interval between the last HIV negative screening test and the first HIV positive screening test, which ranged from 1 day to 24 months. Linear regression methods were used to identify the covariates associated with a negative HIV antibody test followed by a positive test.
RESULTS: Age (p = 0.54), sex (p = 0.78), heterosexual route of infection (p = 0.78), other route (p = 0.40) compared with homosexual route, and estimated year of HIV infection (p value ranged from 0.84 to 0.95) were not associated with a shorter seroconversion interval after multivariate analyses. The presence of an acute HIV illness was the only predictor of a short seroconversion interval (p = 0.006) with a reduction of 84 days of the interval when it was reported.
CONCLUSIONS: No selection bias for demographic characteristics of HIV seroconverters seems associated with the length of the seroconversion interval, at least for intervals < or = 24 months.

Entities:  

Mesh:

Year:  2001        PMID: 11714946      PMCID: PMC1744420          DOI: 10.1136/sti.77.6.446

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  10 in total

1.  Antiretroviral treatment among HIV-1 seroconverters from Lyon, France (1985-1998). Lyon CISIH Collaborators.

Authors:  M Dhenain; P Vanhems; J Fabry; C Chidiac; D Peyramond; J L Touraine; C Trepo; R P Gilibert
Journal:  AIDS       Date:  1999-12-03       Impact factor: 4.177

2.  Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups.

Authors:  A N Phillips; S Grabar; J M Tassie; D Costagliola; J D Lundgren; M Egger
Journal:  AIDS       Date:  1999-10-22       Impact factor: 4.177

3.  Modeling and variable selection in epidemiologic analysis.

Authors:  S Greenland
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

4.  Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.

Authors:  R H Lyles; A Muñoz; T E Yamashita; H Bazmi; R Detels; C R Rinaldo; J B Margolick; J P Phair; J W Mellors
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

5.  Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship.

Authors:  P Vanhems; J Lambert; D A Cooper; L Perrin; A Carr; B Hirschel; J Vizzard; S Kinloch-de Loës; R Allard
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

6.  Category of exposure to HIV and age in the progression to AIDS: longitudinal study of 1199 people with known dates of seroconversion. HIV Italian Seroconversion Study Group.

Authors:  P Pezzotti; A N Phillips; M Dorrucci; A C Lepri; N Galai; D Vlahov; G Rezza
Journal:  BMJ       Date:  1996-09-07

7.  Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study Group.

Authors:  N Carré; C Deveau; F Belanger; F Boufassa; A Persoz; C Jadand; C Rouzioux; J F Delfraissy; D Bucquet
Journal:  AIDS       Date:  1994-06       Impact factor: 4.177

8.  Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study.

Authors:  P J Veugelers; K A Page; B Tindall; M T Schechter; A R Moss; W W Winkelstein; D A Cooper; K J Craib; E Charlebois; R A Coutinho
Journal:  Am J Epidemiol       Date:  1994-10-15       Impact factor: 4.897

9.  Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency virus type 1 (HIV-1)-infected men with known dates of seroconversion.

Authors:  T R O'Brien; D R Hoover; P S Rosenberg; B Chen; R Detels; L A Kingsley; J Phair; A J Saah
Journal:  Am J Epidemiol       Date:  1995-09-15       Impact factor: 4.897

10.  Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group.

Authors:  G R Kaufmann; P Cunningham; A D Kelleher; J Zaunders; A Carr; J Vizzard; M Law; D A Cooper
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

  10 in total
  1 in total

1.  The Development and Implementation of an Outreach Program to Identify Acute and Recent HIV Infections in New York City.

Authors:  Richard Silvera; Dylan Stein; Richard Hutt; Robert Hagerty; Demetre Daskalakis; Fred Valentine; Michael Marmor
Journal:  Open AIDS J       Date:  2010-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.